epigallocatechin gallate has been researched along with Blood Pressure, High in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (21.43) | 29.6817 |
2010's | 7 (50.00) | 24.3611 |
2020's | 4 (28.57) | 2.80 |
Authors | Studies |
---|---|
Lee, SK; Ling, WC; Mohd Sabri, NA; Murugan, DD | 1 |
Chin, JH; Lee, SK; Ling, WC; Parn, KW | 1 |
Chen, X; Ji, X; Li, J; Liu, S; Luo, D; Ma, X; Xu, J; Xu, X; Zhao, J; Zhu, X | 1 |
Azevedo, L; Boscacci Marques, M; Daguer, H; Escher, GB; Granato, D; Inés Genovese, M; Molognoni, L; Oh, WY; Santos, JS; Shahidi, F; Vieira do Carmo, M; Wen, M; Zhang, L | 1 |
Baba, A; Kochi, T; Kubota, M; Moriwaki, H; Ohno, T; Shimizu, M; Shirakami, Y; Tanaka, T; Terakura, D; Tsurumi, H | 1 |
Arazi, H; Kheirkhah, J; Samami, N; Taati, B | 1 |
Nanjo, F; Takagaki, A | 1 |
Bai, J; Chen, WS; Cui, W; Gao, HL; Huo, CJ; Kang, YM; Kou, B; Li, HB; Li, X; Liu, KL; Qi, J; Shi, XL; Yi, QY; Yu, XJ; Zhang, DD; Zhu, GQ | 1 |
Chen, DD; Dong, YG; He, JG; Liu, D | 1 |
Kamei, M; Kurita, I; Maeda-Yamamoto, M; Tachibana, H | 1 |
Li, Z; Vanhoutte, PM; Wang, Y | 1 |
Chang, KC; Chang, WJ; Soung, HS; Wang, MH | 1 |
Huang, Y; Hui, RT; Li, HL; Liang, CC; Liu, DP; Liu, G; Liu, YQ; Wang, AB; Wei, C; Wei, YS; Williams, GM; Zhang, CN | 1 |
Choi, MS; Jang, YH; Kim, AR; Kim, JM; Lee, MY; Lee, SR; Lee, YC; Mun, KC; Park, HR; Park, NH; Shin, HY | 1 |
2 trial(s) available for epigallocatechin gallate and Blood Pressure, High
Article | Year |
---|---|
The effect of three weeks green tea extract consumption on blood pressure, heart rate responses to a single bout resistance exercise in hypertensive women.
Topics: Adult; Analysis of Variance; Antioxidants; Blood Pressure; Cardiovascular Diseases; Catechin; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Hypertension; Middle Aged; Plant Extracts; Resistance Training; Risk Factors; Tea; Treatment Outcome | 2014 |
Antihypertensive effect of Benifuuki tea containing O-methylated EGCG.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Camellia sinensis; Catechin; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Peptidyl-Dipeptidase A; Plant Extracts; Tea | 2010 |
12 other study(ies) available for epigallocatechin gallate and Blood Pressure, High
Article | Year |
---|---|
Epigallocatechin gallate (EGCG) alleviates vascular dysfunction in angiotensin II-infused hypertensive mice by modulating oxidative stress and eNOS.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Cyclic GMP; Endothelium, Vascular; Guanosine Monophosphate; Hypertension; Mice; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Reactive Oxygen Species | 2022 |
Safety and Efficacy of Dietary Epigallocatechin Gallate Supplementation in Attenuating Hypertension via Its Modulatory Activities on the Intrarenal Renin-Angiotensin System in Spontaneously Hypertensive Rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Dietary Supplements; Hypertension; Rats; Rats, Inbred SHR; Renin-Angiotensin System | 2022 |
(-)-Epigallocatechin-3-gallate (EGCG) attenuates salt-induced hypertension and renal injury in Dahl salt-sensitive rats.
Topics: Acute Kidney Injury; Administration, Oral; Animals; Apoptosis; Catechin; Cells, Cultured; Disease Models, Animal; Fibroblasts; Hypertension; Malondialdehyde; Phytotherapy; Rats; Rats, Inbred Dahl; Receptors, Laminin; Sodium Chloride, Dietary | 2020 |
A new analytical concept based on chemistry and toxicology for herbal extracts analysis: From phenolic composition to bioactivity.
Topics: A549 Cells; alpha-Amylases; Angiotensins; Animals; Antioxidants; Aspalathus; Camellia sinensis; Catechin; Cell Line; Cholesterol, LDL; DNA Cleavage; Hesperidin; Humans; Hypertension; Ilex paraguariensis; Male; Oxygen Radical Absorbance Capacity; Phenols; Phytochemicals; Plant Extracts; Plant Leaves; Quercetin; Rats; Rats, Wistar; Rutin | 2020 |
Non-alcoholic steatohepatitis and preneoplastic lesions develop in the liver of obese and hypertensive rats: suppressing effects of EGCG on the development of liver lesions.
Topics: Angiotensin II; Animals; Anticarcinogenic Agents; Catechin; Fatty Liver; Gene Expression; Hypertension; Interleukin-6; Lipid Peroxidation; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Peptidyl-Dipeptidase A; Precancerous Conditions; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Tumor Necrosis Factor-alpha | 2014 |
Effects of Metabolites Produced from (-)-Epigallocatechin Gallate by Rat Intestinal Bacteria on Angiotensin I-Converting Enzyme Activity and Blood Pressure in Spontaneously Hypertensive Rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Bacteria; Blood Pressure; Catechin; Hypertension; Intestines; Lactones; Male; Rats; Rats, Inbred SHR; Tea; Valerates | 2015 |
Chronic infusion of epigallocatechin-3-O-gallate into the hypothalamic paraventricular nucleus attenuates hypertension and sympathoexcitation by restoring neurotransmitters and cytokines.
Topics: Animals; Antioxidants; Arterial Pressure; Catechin; Cytokines; Hypertension; Injections; Male; Neurotransmitter Agents; Norepinephrine; Oxidative Stress; Paraventricular Hypothalamic Nucleus; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reactive Oxygen Species; Sympathetic Nervous System | 2016 |
Epigallocatechin-3-gallate attenuates cardiac hypertrophy in hypertensive rats in part by modulation of mitogen-activated protein kinase signals.
Topics: Animals; Antioxidants; Atrial Natriuretic Factor; Catalase; Catechin; Disease Models, Animal; DNA, Mitochondrial; Electron Transport Chain Complex Proteins; Enzyme Activation; Glutathione Peroxidase; Hemodynamics; Hypertension; Hypertrophy, Left Ventricular; Male; Malondialdehyde; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mitochondria, Heart; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinases; Myocardium; Myosin Heavy Chains; Natriuretic Peptide, Brain; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Superoxide Dismutase; Transcription Factor AP-1 | 2009 |
Epigallocatechin gallate elicits contractions of the isolated aorta of the aged spontaneously hypertensive rat.
Topics: Acetylcholine; Adenosine Triphosphate; Aging; Animals; Antioxidants; Aorta, Thoracic; Catechin; Dose-Response Relationship, Drug; Endothelium, Vascular; Hypertension; Male; Microscopy, Confocal; Muscle Contraction; Oxidative Stress; Prostaglandins; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reactive Oxygen Species; Tea | 2011 |
(-)-Epigallocatechin-3-gallate decreases the impairment in learning and memory in spontaneous hypertension rats.
Topics: Animals; Antioxidants; Blood Pressure; Catechin; Hippocampus; Hypertension; Learning Disabilities; Lipid Peroxidation; Male; Maze Learning; Memory Disorders; Motor Activity; Oxidative Stress; Rats; Rats, Inbred SHR; Reactive Oxygen Species; Tea | 2012 |
Epigallocathechin-3 gallate inhibits cardiac hypertrophy through blocking reactive oxidative species-dependent and -independent signal pathways.
Topics: Angiotensin II; Animals; Animals, Newborn; Antioxidants; Blotting, Northern; Blotting, Western; Cardiomegaly; Catechin; Electrophoretic Mobility Shift Assay; Enzyme Activation; ErbB Receptors; Hypertension; Male; MAP Kinase Kinase 4; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Transcription Factor AP-1 | 2006 |
Polyphenol (-)-epigallocatechin gallate protection from ischemia/reperfusion-induced renal injury in normotensive and hypertensive rats.
Topics: Animals; Blood Urea Nitrogen; Catechin; Creatinine; Disease Models, Animal; Flavonoids; Hypertension; Phenols; Polyphenols; Rats; Rats, Inbred SHR; Reference Values; Renal Circulation; Reperfusion Injury | 2006 |